UniProtKB/Swiss-Prot Q13873: Variant p.Ser775Asn

Bone morphogenetic protein receptor type-2
Gene: BMPR2
Feedback?

Variant information Variant position:

775 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Serine (S) to Asparagine (N) at position 775 (S775N, p.Ser775Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and polar (S) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Unchanged subcellular localization. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs2228545 [ dbSNP | Ensembl ]

Sequence information Variant position:

775 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1038 The length of the canonical sequence.
Location on the sequence:

PTSLPLNTKNSTKEPRLKFG S KHKSNLKQVETGVAKMNTIN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PTSLPLNTKNSTKEPRLKFGSKHKSNLKQVETGVAKMNTIN

Mouse                         PTSLPLNTKNSTKEPRLKFGNKHKSNLKQVETGVAKMNTIN

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	27 – 1038	Bone morphogenetic protein receptor type-2
Topological domain	172 – 1038	Cytoplasmic
Alternative sequence	531 – 1038	Missing. In isoform 2.

Literature citations
Patterns of somatic mutation in human cancer genomes.
Greenman C.; Stephens P.; Smith R.; Dalgliesh G.L.; Hunter C.; Bignell G.; Davies H.; Teague J.; Butler A.; Stevens C.; Edkins S.; O'Meara S.; Vastrik I.; Schmidt E.E.; Avis T.; Barthorpe S.; Bhamra G.; Buck G.; Choudhury B.; Clements J.; Cole J.; Dicks E.; Forbes S.; Gray K.; Halliday K.; Harrison R.; Hills K.; Hinton J.; Jenkinson A.; Jones D.; Menzies A.; Mironenko T.; Perry J.; Raine K.; Richardson D.; Shepherd R.; Small A.; Tofts C.; Varian J.; Webb T.; West S.; Widaa S.; Yates A.; Cahill D.P.; Louis D.N.; Goldstraw P.; Nicholson A.G.; Brasseur F.; Looijenga L.; Weber B.L.; Chiew Y.-E.; DeFazio A.; Greaves M.F.; Green A.R.; Campbell P.; Birney E.; Easton D.F.; Chenevix-Trench G.; Tan M.-H.; Khoo S.K.; Teh B.T.; Yuen S.T.; Leung S.Y.; Wooster R.; Futreal P.A.; Stratton M.R.;
Nature 446:153-158(2007)
Cited for: VARIANT [LARGE SCALE ANALYSIS] ASN-775; Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
Pousada G.; Baloira A.; Vilarino C.; Cifrian J.M.; Valverde D.;
PLoS ONE 9:E100261-E100261(2014)
Cited for: VARIANTS PPH1 LEU-77; PHE-84; TYR-87; LEU-92; PRO-162; ASN-264 AND MET-341; VARIANT ASN-775; Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension.
Pousada G.; Lupo V.; Castro-Sanchez S.; Alvarez-Satta M.; Sanchez-Monteagudo A.; Baloira A.; Espinos C.; Valverde D.;
Sci. Rep. 7:1923-1923(2017)
Cited for: VARIANTS PPH1 ARG-64; PHE-84; HIS-109; ALA-138; 218-TYR--LEU-1038 DEL; GLY-248; 298-TRP--LEU-1038 DEL AND ARG-467; CHARACTERIZATION OF VARIANTS PPH1 ARG-64; LEU-77; TYR-87; LEU-92; HIS-109; ALA-138; PRO-162; 218-TYR--LEU-1038 DEL; GLY-248; ASN-264; 298-TRP--LEU-1038 DEL; MET-341 AND ARG-467; CHARACTERIZATION OF VARIANT ASN-775;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.